Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pharmather Holdings Ltd C.PHRM

Alternate Symbol(s):  PHRRF

psychedelics
PharmaTher Holdings Ltd. is a Canada-based specialty pharmaceutical company. The Company develops and commercializes specialty pharmaceuticals exhibiting growing adoption and permitting delivery methods to enhance patient outcomes. Its lead product is KETARX (racemic ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, mental health, and neurological indications. The Company is also commercializing PharmaPatch (microneedle patch) with its partners to deliver psychedelics and drugs to treat infectious diseases.


CSE:PHRM - Post by User

Pharmather Holdings Ltd > News...PD001 gets approval!!
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(191)
•••
Post by Guytoruleon Aug 19, 2024 8:57am
102 Views
Post# 36185603

News...PD001 gets approval!!

News...PD001 gets approval!!Subsidiary "Sairiyo" gets Australian approval to commence trials for their drug PD001 phase 1 for responsive cancers and infectious deceases including Covid 19. Then applications to FDA for phase 2 and 3...Good news...now we wait for their KETARX  product FINAL APPROVAL by FDA with its goal date of October 29th  around the corner..
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities